GLP1R and hydrops fetalis: There are no data available in patients with HFpEF, but more than 80% of these patients are overweight or obese, therefore, taking into account that GLP-1 RAs produce a weight loss that varies between 5% and 10%, they could contribute to improve the risk of HF and the cardiovascular profile of these patients (88).